TOFEZV 5 is a specialized immunosuppressant containing Tofacitinib IP 5 mg, primarily utilized as a Janus Kinase (JAK) inhibitor to treat moderate-to-severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by targeting specific inflammatory pathways to reduce joint pain, swelling, and stiffness while effectively slowing the progression of bone and tissue damage in chronic conditions. Designed for patients who have shown inadequate response to conventional DMARDs, this medication provides a powerful oral alternative to injectable biologics, ensuring enhanced mobility and a better quality of life through high-efficacy formulation.
TOFEZV 5
Composition:
Tofacitinib IP 5 mg
Packing:
10 X 10
